BMS to cut use of HCFCs to settle US clean air claims
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibbhas agreed to use only non-ozone-depleting refrigerants at multiple sites at a combined cost of $3.65 million in order to resolve alleged violations related to clear-air standards, according to the US justice department and the US Environmental Protection Agency(EPA).